Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the ...
Takeda-backed Ascentage Pharma Group (AAPG) (ASPHF), which is developing treatments for blood cancers, has set terms for a ...
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection ...
Hosted on MSN1dOpinion
New Strong Buy Stocks for January 21stList today: CareDx, Inc CDNA: This diagnostic solutions company for transplant patients and caregivers has seen the Zacks ...
aTyr Pharma, Inc. (Nasdaq ... today announced that the Company will be changing its ticker symbol from “LIFE” to “ATYR.” Effective at the market open on June 5, 2024, the Company ...
Generics businesses achieve pretty defendable margins, yet their valuations are at material discounts to most of the Big ...
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...
Through its engagement with OTC pharmaceutical suppliers, logistics companies, and merchants on Chinese e-commerce platforms, Joint Cross Border provides a convenient one-stop solution for Mainland ...
New NE Director sees potential and I like his quote: "I believe Nuvec will drive long-term value through licensing deals and partnerships in the NEAR term". I'm taking it that he is privy to all ...
Avadel Pharmaceuticals PLC (AVDL) reports significant revenue increase and outlines optimistic projections for 2025 amidst market expansion challenges. Avadel Pharmaceuticals PLC (AVDL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback